Placenta-first risk stratification mode
In pregnancies with suspected or proven CPM, placental genotype and function determine risk more than fetal karyotype.
STEP 1: Define the placental genetic risk tier
Tier P0 – No placental genetic signal
- Normal NIPT
- Normal CVS / amnio
- No discordance
Placental risk: Baseline
Management: Routine obstetric care
Tier P1 – Cytotrophoblast-limited abnormality (CPM type 1)
Typical scenario
- NIPT positive
- Amniocentesis normal
- CVS STC abnormal, LTC normal
Biology
- Usually mitotic
- Abnormal cells confined to trophoblast
- Placental architecture often preserved
Placental risk
- Low but not zero
Clinical expectation
- Mostly normal growth
- Small increase in FGR risk
Tier P2 – Mesenchymal or mixed placental abnormality (CPM type 2 or 3)
Typical scenarios
- Discordant CVS cultures
- Positive NIPT + abnormal LTC
- Known CPM after amnio
- Trisomy rescue suspected
Biology
- Often early mitotic or meiotic
- Placental villous core affected
- Vascular and exchange dysfunction likely
Placental risk
- Moderate to high
STEP 2: Overlay chromosome-specific placental behavior
Some chromosomes are disproportionately placentotoxic
| Chromosome | Placental impact | Typical outcome |
|---|---|---|
| 16 | Severe | Early FGR, IUFD risk |
| 22 | Severe | FGR, preeclampsia |
| 15 | Moderate | UPD syndromes |
| 7 | Moderate | FGR, Silver–Russell |
| 18 | Moderate | CPM common, variable |
| 21 | Mild | Often compensated |
STEP 3: Add functional placental phenotype
Ultrasound and Doppler markers
- Uterine artery PI
- Umbilical artery PI
- Placental thickness
- Placental lakes / cysts
- Cord insertion abnormalities
Growth trajectory
- Early symmetric FGR → genetic/placental
- Late asymmetric FGR → functional placental failure
STEP 4: The integrated placenta-first risk matrix
Low risk
- CPM type 1
- Non-placentotoxic chromosome
- Normal uterine artery Doppler
- Normal growth
Management
- Growth scans every 4 weeks
- Routine third-trimester surveillance
Intermediate risk
- CPM type 1 with placentotoxic chromosome
- OR
- CPM type 2 with normal Dopplers
Management
- Growth every 3 weeks
- Umbilical artery Doppler
- Low-dose aspirin if early
- Lower threshold for steroids
High risk
- CPM type 3
- Meiotic trisomy rescue
- Trisomy 16 or 22
- Abnormal uterine artery Doppler
- Early FGR
Management
- Growth every 2 weeks
- Full Doppler surveillance
- Early antenatal steroids
- Delivery planning in tertiary unit
STEP 6: Prevention of adverse outcomes
It catches early
- “Unexplained” early FGR
- Late IUFD with normal fetus
- Preeclampsia with normal genetics
- Discordant NIPT cases dismissed as false positives
Placenta-first stratification recognizes CPM as a placental disease with fetal consequences, allowing risk prediction even when fetal karyotype is normal.